Harvest Fund Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.34M | Sell |
5,953
-3,087
| -34% | -$1.98M | 0.14% | 105 |
|
|
2025
Q4 | $6.12M | Buy |
9,040
+1,225
| +16% | +$834K | 0.23% | 83 |
|
|
2025
Q3 | $4.99M | Buy |
7,815
+1,653
| +27% | +$1M | 0.21% | 85 |
|
|
2025
Q2 | $3.3M | Buy |
6,162
+802
| +15% | +$384K | 0.16% | 106 |
|
|
2025
Q1 | $2.25M | Buy |
5,360
+541
| +11% | +$235K | 0.11% | 132 |
|
|
2024
Q4 | $1.95M | Buy |
4,819
+1,028
| +27% | +$451K | 0.09% | 145 |
|
|
2024
Q3 | $1.92M | Buy |
3,791
+1,153
| +44% | +$560K | 0.11% | 123 |
|
|
2024
Q2 | $1.28M | Sell |
2,638
-986
| -27% | -$495K | 0.09% | 135 |
|
|
2024
Q1 | $1.96M | Buy |
3,624
+2,208
| +156% | +$1.21M | 0.18% | 95 |
|
|
2023
Q4 | $534K | Buy |
1,416
+502
| +55% | +$236K | 0.08% | 113 |
|
|
2023
Q3 | $400K | Sell |
914
-88
| -9% | -$43.9K | 0.07% | 133 |
|
|
2023
Q2 | $503K | Buy |
1,002
+191
| +24% | +$91.5K | 0.1% | 104 |
|
|
2023
Q1 | $405K | Buy |
811
+523
| +182% | +$250K | 0.09% | 117 |
|
|
2022
Q4 | $101K | Buy |
288
+229
| +388% | +$88.9K | 0.03% | 334 |
|
|
2022
Q3 | $19K | Buy |
59
+16
| +37% | +$5.88K | 0.01% | 564 |
|
|
2022
Q2 | $15K | Hold |
43
| – | – | ﹤0.01% | 572 |
|
|
2022
Q1 | $23K | Sell |
43
-1,039
| -96% | -$547K | ﹤0.01% | 565 |
|
|
2021
Q4 | $714K | Sell |
1,082
-214
| -17% | -$134K | 0.12% | 72 |
|
|
2021
Q3 | $805K | Sell |
1,296
-181
| -12% | -$122K | 0.18% | 45 |
|
|
2021
Q2 | $943K | Hold |
1,477
| – | – | 0.1% | 56 |
|
|
2021
Q1 | $722K | Sell |
1,477
-15
| -1% | -$7.51K | 0.07% | 65 |
|
|
2020
Q4 | $745K | Buy |
1,492
+220
| +17% | +$98.4K | 0.06% | 61 |
|
|
2020
Q3 | $499K | Buy |
1,272
+852
| +203% | +$315K | 0.04% | 86 |
|
|
2020
Q2 | $140K | Buy |
+420
| New | +$122K | 0.01% | 189 |
|
|
2019
Q4 | – | Sell |
-746
| Closed | -$203K | – | 442 |
|
|
2019
Q3 | $203K | Hold |
746
| – | – | 0.03% | 121 |
|
|
2019
Q2 | $205K | Buy |
+746
| New | +$184K | 0.02% | 112 |
|
|
2018
Q4 | – | Sell |
-917
| Closed | -$229K | – | 383 |
|
|
2018
Q3 | $229K | Buy |
917
+729
| +388% | +$177K | 0.04% | 138 |
|
|
2018
Q2 | $41K | Hold |
188
| – | – | 0.01% | 221 |
|
|
2018
Q1 | $35K | Buy |
+188
| New | +$34.7K | 0.01% | 201 |
|
|
2017
Q3 | – | Sell |
-192
| Closed | -$31K | – | 203 |
|
|
2017
Q2 | $31K | Hold |
192
| – | – | ﹤0.01% | 187 |
|
|
2017
Q1 | $30K | Hold |
192
| – | – | 0.01% | 185 |
|
|
2016
Q4 | $23K | Buy |
+192
| New | +$21.9K | 0.01% | 198 |
|
Other funds holding IDXX
VCM
VPM
Harvest Fund Management's IDXX Position: Q1 2026 in Review
Harvest Fund Management reduced its Idexx Laboratories (IDXX) stake by 34% in Q1 2026, selling an estimated $1.98M and leaving 5,953 shares worth $3.34M. The position accounts for 0.14% of the portfolio, ranked #105.
Harvest Fund Management first reported a position in IDXX in Q4 2016 and has held it in 32 quarters since. The position peaked at $6.12M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Harvest Fund Management held 5,953 shares of Idexx Laboratories worth $3.34M as of Q1 2026.
- Harvest Fund Management sold 3,087 Idexx Laboratories shares in Q1 2026, an estimated $1.98M.
- Idexx Laboratories made up 0.14% of Harvest Fund Management's portfolio in Q1 2026, its #105 holding.
- Harvest Fund Management first reported a position in Idexx Laboratories in Q4 2016 and has held it in 32 quarters since.
- Harvest Fund Management's Idexx Laboratories position peaked at $6.12M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.